Laboratory abnormalities at the onset of treatment of end-stage renal disease: Are there racial or socioeconomic disparities in care?

Archives of Internal Medicine

Volumn 167, Issue 10, 2007, Pages 1083-1091

  Ward, Michael M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; RECOMBINANT ERYTHROPOIETIN; SERUM ALBUMIN;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DIALYSIS; DISEASE ASSOCIATION; DRUG USE; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH INSURANCE; HEMATOCRIT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; GLOMERULAR FILTRATION RATE; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; MINORITY GROUPS; SERUM ALBUMIN; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 34249709588     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.10.1083     Document Type: Article

References (51)

1. United States Renal Data System. USRDS 2005 Annual Data Report: Atlas of Endstage Renal Disease in the United States. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006.
2. Ratcliffe PJ, Phillips RE, Oliver DO. Late referral for maintenance dialysis. Br Med J (Clin Res Ed). 1984;288:441-443.
3. Jungers P, Zingraff J, Albouze G, et al. Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant. 1993;8:1089-1093.
4. Roubicek C, Brunet P, Huiart L, et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis. 2000;36:35-41.
5. Roderick P, Jones C, Drey N, et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant. 2002;17:1252-1259.
6. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479-486.
7. Kessler M, Frimat L, Panescu V, Briançon S. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorranine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42:474-485.
8. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310-318.
9. Obialo CI, Ofili EO, Quarshie A, Martin PC. Ultralate referral and presentation for renal replacement therapy: socioeconomic implications. Am J Kidney Dis. 2005;46:881-886.
10. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis. 1996;28:841-845.
11. Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in hemodialysis patients. Nephrol Dial Transplant. 1997;12:2111-2116.
12. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10:1281-1286.
13. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJG. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol. 1999;10:1793-1800.
14. Curtis BM, Barrett BJ, Jindal K, et al. Canadian survey of clinical status at dialysis initiation 1998-1999: a multicenter prospective survey. Clin Nephrol. 2002;58:282-288.
15. Lorenzo V, Martin M, Rufino M, Hernández D, Torres A, Ayus JC. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis. 2004;43:999-1007.
16. Churchill DN, Taylor DW, Cook RJ, et al. Canadian hemodialysis mortality study. Am J Kidney Dis. 1992;19:214-234.
17. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis. 1994;23:272-282.
18. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7:728-736.
19. Fink JC, Burdick RA, Kurth SJ, et al. Significance of serum creatinine values in end-stage renal disease patients. Am J Kidney Dis. 1999;34:694-701.
20. Li S, Collins AJ. Association of hematocrit value with cardiac morbidity and mortality in incident hemodialysis patients. Kidney Int. 2004;65:626-633.
21. Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004;43:61-66.
22. Regidor DL, Kopple JD, Kovesdy CP, et al. Associations between changes in hemoglobin and administered erythopoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol. 2006;17:1181-1191.
23. Frankenfield DL, Rocco MV, Frederick PR, Pugh J, McClellan WM, Owen WF Jr; National ESRD Core Indicators Work Group. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Am J Kidney Dis. 1999;34:721-730.
24. Sehgal AR. Impact of quality improvement efforts on race and sex disparities in hemodialysis. JAMA. 2003;289:996-1000.
25. Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998;280:1148-1152.
26. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation: clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343:1537-1544.
27. Wolfe RA, Ashby VB, Milford EL, et al. Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis. 2000;36:1025-1033.
28. Yeates KE, Schaubel DE, Cass A, Sequist TD, Ayanian JZ. Access to renal transplantation for minority patients with ESRD in Canada. Am J Kidney Dis. 2004;44:1083-1089.
29. Ifudu O, Dawood M, Iofel Y, Valcourt JS, Friedman EA. Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis. 1999;33:728-733.
30. Iofel Y, Dawood M, Valcourt JS, Ifudu O. Initiation of dialysis is not delayed in whites with progressive renal failure. ASAIO J. 1998;44:M598-M600.
31. Obrador GT, Arora P, Kraus AT, Ruthazer R, Gereira BJG, Levey AS. Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int. 1999;56:2227-2235.
32. Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJG. Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol. 2000;11:2351-2357.
33. Soucie JM, Neylan JF, McClellan W. Race and sex differences in the identification of candidates for renal transplantation. Am J Kidney Dis. 1992;19:414-419.
34. Kasiske BL, London W, Ellison MD. Race and socioeconomic factors influencing early placement on the kidney transplant waiting list. J Am Soc Nephrol. 1998;9:2142-2147.
35. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol. 2000;11:A0828.
36. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12:703-711.
37. Diez-Roux AV, Kiefe CI, Jacobs DR Jr, et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies [published correction appears in Ann Epidemiol. 2001;30:924]. Ann Epidemiol. 2001;11:395-405.
38. Census 2000 Summary File 3 - United States. http://factfinder.census.gov. Accessed December 22, 2005.
39. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23:16-22.
40. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors. Arch Intern Med. 1995;155:1201-1208.
41. Klag MJ, Whelton PK, Randall BL, Meaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and White men: 16-year MRFIT findings. JAMA. 1997;277:1293-1298.
42. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. 2nd ed. Belmont, Calif: Brooks/Cole; 1982.
43. Doescher MP, Saver BG, Franks P, Fiscella K. Racial and ethnic disparities in perceptions of physician style and trust. Arch Fam Med. 2000;9:1156-1163.
44. Berrios-Rivera JP, Street RL Jr, Garcia Popa-Lisseanu MG, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 2006;55:385-393.
45. Owen WF Jr, Szczech LA, Frankenfield DL. Healthcare system interventions for inequality in quality: corrective action through evidence-based medicine. J Natl Med Assoc. 2002;94(suppl):83S-91S.
46. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192-204.
47. Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19:54-61.
48. Abuelo JG, Shemin D, Chazan JA. Serum creatinine concentration at the onset of uremia: higher levels in black males. Clin Nephrol. 1992;37:303-307.
49. Cody J, Daly C, Campbell M, et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev. 2005;20:CD003266.
50. Obrador GT, Roberts T, St. Peter WL, Frazier E, Pereira BJ, Collins AJ. Trends in anemia at initiation of dialysis in the United States. Kidney Int. 2001;60:1875-1884.
51. Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R. Choosing area based socioeconomic measures to monitor social inequalities in low birth weight and childhood lead poisoning: the Public Health Disparities Geocoding Project (US). J Epidemiol Community Health. 2003;57:186-199.